Weber M, Kersting D, Riemann B, Brandenburg T, et al. Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancer With MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study. Clin Cancer Res 2022 May 20. pii: 699089. doi: 10.1158/1078-0432.CCR-22-0437.
PMID: 35594174